The Food and Drug Administration, as expected, approved KarXT, the first new type of drug for schizophrenia in decades. It appears to be effective, but its main advantage is milder side effects.
Correction Sept. 26, 2024
The initial version of this online summary incorrectly stated that the Food and Drug Administration had approved KarXT. The broadcast story reported that the agency was expected to approve the drug soon. The FDA then approved the drug, as expected, and both the summary and broadcast story were updated.
